The Mass Spectrometry Shared Resource is a specialized facility with the primary goal of protein identification, characterization and quantitation. CSHL has had a peptide sequencing and proteomics facility for over two decades, but the facility was extensively re-equipped in 2008 following the recommendations of the External Advisory Committee, and was housed within the Keck Structural Biology laboratory on the ground floor of the Beckman building. The Resource provides Cancer Center members with access to up-to-date mass spectrometry instrumentation and specialized technical expertise. Services used by the majority of Cancer Center members include protein and protein complex identification, characterization of protein post translational modifications, quantitative peptide MRM assays and quantitative whole-proteome screens using 2D LCMS with iTRAQ or SILAC. More specialized services have undertaken quantitative phosphoproteomic and cysteine proteomics screens, lipid and carbohydrate analyses, metabolomics profiling and specific MRM assays of drugs and other small molecule metabolites. The Shared Resource performs all the data analysis for the quantitative screens and has developed new tools for the merging of large datasets across multiple, independent experiments. All of these services are highly technical and labor intensive. Without the Mass Spectrometry Shared Resource it would be extremely difficult for individual investigators to have access to this type of instrumentation and analyses and these types of services, which are often critical to their research programs. Over the last funding period the Resource has updated HPLC equipment to allow for high-resolution ultra-high pressure liquid chromatography (UHPLC) and built a dedicated 64-processor cluster for database searching. In summary, the Shared Resource provides the user group with state-of-the-art instrumentation and advanced technical support to help accelerate cancer research at CSHL. Over the past five years, the Mass Spectrometry Shared Resource was utilized by 16 Cancer Center members (43% of members), accounting for a majority of its use. This Resource contributed to 29 publications by Cancer Center members over this time period.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA045508-29
Application #
9151082
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
29
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Albrengues, Jean; Shields, Mario A; Ng, David et al. (2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361:
Cheng, Derek; Tuveson, David (2018) Kras in Organoids. Cold Spring Harb Perspect Med 8:
Melnikov, Sergey V; Rivera, Keith D; Ostapenko, Denis et al. (2018) Error-prone protein synthesis in parasites with the smallest eukaryotic genome. Proc Natl Acad Sci U S A 115:E6245-E6253
Cook, Natalie; Basu, Bristi; Smith, Donna-Michelle et al. (2018) A phase I trial of the ?-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer 118:793-801
Pommier, Arnaud; Anaparthy, Naishitha; Memos, Nicoletta et al. (2018) Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science 360:
Krishnan, Navasona; Bonham, Christopher A; Rus, Ioana A et al. (2018) Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development. Nat Commun 9:283
Tiriac, Herve; Bucobo, Juan Carlos; Tzimas, Demetrios et al. (2018) Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment. Gastrointest Endosc 87:1474-1480
Krishnan, Navasona; Felice, Christy; Rivera, Keith et al. (2018) DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease. Genes Dev 32:944-952
Connell, Claire M; Raby, Sophie E M; Beh, Ian et al. (2018) Cancer Immunotherapy Trials Underutilize Immune Response Monitoring. Oncologist 23:116-117
Nattestad, Maria; Goodwin, Sara; Ng, Karen et al. (2018) Complex rearrangements and oncogene amplifications revealed by long-read DNA and RNA sequencing of a breast cancer cell line. Genome Res 28:1126-1135

Showing the most recent 10 out of 380 publications